Clinical trials
Recruiting Recurrence trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2019 | 3 |
| 2022 | 5 |
| 2023 | 9 |
| 2024 | 9 |
| 2025 | 9 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 45 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| AbbVie | 2 |
| Australian & New Zealand Children's Haematology/Oncology Group | 2 |
| Hoffmann-La Roche | 2 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 2 |
| Regeneron Pharmaceuticals | 2 |
| Treeline Biosciences, Inc. | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Amgen | 1 |
| Aptose Biosciences Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 45 |
| Lymphoma, Non-Hodgkin | 9 |
| Neoplasms | 8 |
| Lymphoma | 7 |
| Neoplasm Metastasis | 7 |
| Lymphoma, Follicular | 6 |
| Multiple Myeloma | 6 |
| Lymphoma, B-Cell | 5 |
| Squamous Cell Carcinoma of Head and Neck | 4 |
| Biliary Tract Neoplasms | 3 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.